<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27190433</article-id><article-id pub-id-type="pmc">4868193</article-id><article-id pub-id-type="publisher-id">jpts-2015-992</article-id><article-id pub-id-type="doi">10.1589/jpts.28.1092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Cellular fibronectin response to supervised moderate aerobic training in
patients with type 2 diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alghadir</surname><given-names>Ahmad H.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gabr</surname><given-names>Sami A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Al-Eisa</surname><given-names>Einas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1)</label> Rehabilitation Research Chair, College of Applied Medical
Sciences, King Saud University, KSA</aff><aff id="aff2"><label>2)</label> Department of Anatomy, Faculty of Medicine, Mansoura
University, Egypt</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Sami A. Gabr, Rehabilitation Research Chair, College of Applied Medical
Sciences, King Saud University: P.O. Box 10219 Riyadh 11433, KSA. (E-mail: <email xlink:href="nadalab2009@hotmail.com">nadalab2009@hotmail.com</email>; <email xlink:href="drGabr14@yahoo.com">drGabr14@yahoo.com</email>; <email xlink:href="sgabr@ksu.edu.sa">sgabr@ksu.edu.sa</email>)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>28</volume><issue>4</issue><fpage>1092</fpage><lpage>1099</lpage><history><date date-type="received"><day>18</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>2016&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] Physical activity is one of the most pivotal targets for the prevention and
management of vascular complications, especially endothelial dysfunctions. Cellular
fibronectin is an endothelium-derived protein involved in subendothelial matrix assembly.
Its plasma levels reflect matrix alterations and vessel wall destruction in patients with
type II diabetes. This study investigated the influence of 12 weeks of supervised aerobic
training on cellular fibronectin and its relationship with insulin resistance and body
weight in type II diabetic subjects. [Subjects and Methods] This study included 50 men
with type II diabetes who had a mean age of 48.8 &#x000b1; 14.6&#x02005;years and were randomly divided
into two groups: an aerobic exercise group (12 weeks, three 50 minutes sessions per week)
and control group. To examine changes in cellular fibronectin, glycosylated hemoglobin,
insulin resistance, fasting insulin, fasting blood sugar, and lipid profile, 5&#x02005;ml of blood
was taken from the brachial vein of patients before and 48 hours after completion of the
exercise period and after 12 hours of fasting at rest. Data analysis was performed using
the SPSS-16 software with the independent and paired t-tests. [Results] A significant
decrease was observed in body mass index and body fat percentage in the experimental
group. Compared with the control group, the aerobic exercise group showed a significant
decrease in cellular fibronectin, glycosylated hemoglobin, insulin resistance, fasting
insulin, fasting blood sugar, and lipid profile after 12 weeks of aerobic exercise. The
change in cellular fibronectin showed positive significant correlation with body mass
index, diabetic biomarkers, and physical activity level. [Conclusion] The results showed
that supervised aerobic exercise as a stimulus can change the levels of cellular
fibronectin as matrix metalloproteinase protein a long with improvement of insulin
sensitivity and glycosylated hemoglobin in order to prevent cardiovascular diseases in men
with diabetes</p></abstract><kwd-group><title>Key words</title><kwd>Cellular fibronectin</kwd><kwd>Aerobic training</kwd><kwd>Type II diabetes</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Diabetes is considered one the most serious results of metabolic disorders with major
related complications worldwide, such as cardiovascular disease, nephropathy, retinopathy,
and amputation<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>.</p><p>It has reported that the pathogenesis of vascular diseases accompanying diabetes such as
endothelial dysfunction and atherosclerosis result from the imbalance between relaxing and
contracting endothelial factor which ultimately are associated with future progression of
vascular and end-organ damage<xref rid="r2" ref-type="bibr">2</xref><sup>)</sup>.</p><p>In diabetes mellitus, many factors affect the development of endothelial dysfunction such
as elevated sugar levels and insulin resistance, which in turn increase the probability of
cardiovascular risk and mortality, especially among diabetic patients with obesity,
hypertension, and metabolic syndrome. On the other hand, insulin resistance was shown to be
associated with the progression of endothelial dysfunction to atherosclerosis in individuals
with type 2 diabetes<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>.</p><p>Also, many research studies have reported that the most important step for progression of
arterial diseases is endothelial dysfunction. So, it is very important to evaluate
endothelial function clearly either with vascular function tests or estimation of the
concentrations of specific endothelial proteins<xref rid="r4" ref-type="bibr">4</xref>,
<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>. Fibronectin (FN) is one of the most
reliable proteins that can be estimated as a plasma indicator protein for endothelial
function. It refers to a large category of glycoproteins (440&#x02013;500 kD) that is considered to
be one of the main constituents of the extracellular matrix and plays a potential role in
cell to cell as well as cell to matrix adhesions<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. Most studies have reported that FN protein has different specific
variants that differ in the arrangement of their peptides. The major cellular fibronectin
(CFN) type III variant present in the blood stream (soluble or plasma FN) is specifically
produced and released by endothelial cells during pathological conditions<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>Many studies have reported significant elevation of circulating cFN in many metabolic
syndromes associated with endothelial activation, such as diabetes mellitus, and considered
cFN a specific marker for endothelial cell injury<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. So, the change in the levels of serum or plasma cellular
fibronectin may reflect the extent of matrix changes and vessel wall damage in patients with
diabetes.</p><p>Increases in the extracellular matrix glycoprotein fibronectin and calcification also may
contribute to arterial stiffness with ageing<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>. Previously, it was reported that regular
exercise could enhance the hemostatic physiological changes that could provide significant
protection against major thrombotic events<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>, whereas alterations or impairment in all
thrombotic factors, including fibrinogen and fibronectin concentration were enhanced by
exercise<xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref><sup>)</sup>.</p><p>Habitual aerobic exercise is a first-line therapeutic strategy for reducing the risk of CVD
with ageing<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref><sup>)</sup>. Middle-aged and older
adults who regularly perform aerobic exercise demonstrate less age-associated stiffening of
large elastic arteries compared with their sedentary peers<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r23" ref-type="bibr">23</xref><sup>)</sup>.</p><p>However, the mechanisms by which regular aerobic exercise exerts its favorable effects on
large elastic artery stiffening with ageing have not been established, partly because of
lack of access to these tissues in humans. The limited available data in experimental
animals (forced swimming in rats) do not support an influence of voluntary exercise on whole
artery collagen or elastin<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref><sup>)</sup>. Also, the mechanisms by which regular aerobic exercise
exerts its effects on cFN in type 2 patients have not been established. So we aimed in this
study to evaluate the effect of supervised aerobic training of moderate intensity on plasma
levels of cFN and its relationship with insulin resistance and body weight in subjects with
type 2 diabetes.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>Fifty subjects diagnosed as having type 2 diabetes mellitus more than 5&#x02005;years previously
with normal or near normal body weights participated in this study. The diagnosis of
diabetes mellitus (DM) was based on the American Diabetes Association criteria for DM2
(fasting plasma glucose level higher than 126&#x02005;mg/dl and/or glucose level exceeding 200&#x02005;mg/dl
at 2 hours in the 75&#x02005;g oral glucose tolerance test<xref rid="r28" ref-type="bibr">28</xref><sup>)</sup>. The subjects were divided into two groups: an aerobic exercise
group (12 weeks, three 50 minutes sessions per week) and control group (sedentary
lifestyle). General characteristics of the subjects are shown in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Demographic, clinical, and biochemical characteristics of the patients with type
2 diabetes in both the aerobic exercise and control groups (n=50)</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Variables*</th><th valign="top" align="center" rowspan="1" colspan="1">Aerobic exercise (n=25)</th><th valign="top" align="center" rowspan="1" colspan="1">Control (25)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">48.8 &#x000b1; 14.6</td><td align="center" valign="top" rowspan="1" colspan="1">48.7 &#x000b1; 3.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">165 &#x000b1; 2.2</td><td align="center" valign="top" rowspan="1" colspan="1">161.4 &#x000b1; 2.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">71.9 &#x000b1; 2.4</td><td align="center" valign="top" rowspan="1" colspan="1">70.8 &#x000b1; 3.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">26.41 &#x000b1; 4.3*</td><td align="center" valign="top" rowspan="1" colspan="1">27.18 &#x000b1; 5.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body fat (%)</td><td align="center" valign="top" rowspan="1" colspan="1">31.8 &#x000b1; 2.3*</td><td align="center" valign="top" rowspan="1" colspan="1">29.7 &#x000b1; 1.85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes duration (years)</td><td align="center" valign="top" rowspan="1" colspan="1">13.5 &#x000b1; 9.8*</td><td align="center" valign="top" rowspan="1" colspan="1">10.9 &#x000b1; 8.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c (%)</td><td align="center" valign="top" rowspan="1" colspan="1">9.7 &#x000b1; 1.2**</td><td align="center" valign="top" rowspan="1" colspan="1">8.1 &#x000b1; 0.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total cholesterol (mmol/l)</td><td align="center" valign="top" rowspan="1" colspan="1">5.9 &#x000b1; 0.9*</td><td align="center" valign="top" rowspan="1" colspan="1">4.7&#x000b1; 0.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL cholesterol (mmol/l)</td><td align="center" valign="top" rowspan="1" colspan="1">1.8 &#x000b1; 0.7*</td><td align="center" valign="top" rowspan="1" colspan="1">1.7 &#x000b1; 0.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Triglycerides (mmol/l)</td><td align="center" valign="top" rowspan="1" colspan="1">1.9 &#x000b1; 1.3*</td><td align="center" valign="top" rowspan="1" colspan="1">1.6 &#x000b1; 1.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL cholesterol (mmol/l)</td><td align="center" valign="top" rowspan="1" colspan="1">3.7 &#x000b1; 1.1*</td><td align="center" valign="top" rowspan="1" colspan="1">3.1 &#x000b1; 0.96</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment for hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">11 (25)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (25)</td></tr></tbody></table><table-wrap-foot><p>Data presented as the mean &#x000b1;SD. The paired sample t-test revealed significant
differences in within group comparisons (*p&#x0003c;0.05, **p&#x0003c;0.01, ***p&#x0003c;0.001)</p></table-wrap-foot></table-wrap>. Standardized physical examination, demographic measures, and collection of
serum samples were performed before and after the 12- weeks of moderate aerobic training
program. Participants with obesity (body mass index [BMI] &#x02265; 30 (kg/m<sup>2</sup>), type 1
diabetes, smokers, severe diabetic complications, metabolic syndromes, viral hepatitis, and
obvious heart diseases were excluded from the study. Before starting the study, the
participants were requested to provide an informed consent. This study was approved by the
ethics committee of Rehabilitation Research Chair (RRC), King Saud University, KSA, under
file number/ ID: RRC- 2013-016.</p><p>The participants in the aerobic exercise group performed an exercise program designed
according to Karvonen&#x02019;s formula<xref rid="r29" ref-type="bibr">29</xref><sup>)</sup> three
times per week for 12 weeks. The training intensity of each intervention was selected
according to the maximum and resting heart rate of each participant. The pre training heart
rates (THR max; 60&#x02013;70% for 45&#x02013;60&#x02005;min) of the participants were calculated after performing
warm-up exercises for 5 to 10 minutes using a treadmill, bicycle, and stair master as
previously reported<xref rid="r30" ref-type="bibr">30</xref>, <xref rid="r31" ref-type="bibr">31</xref><sup>)</sup>. An automatic portable heart rate meter (Polar Electro,
Kempele, Finland) was used to calculate the exact heart rate of each participant. An
exercise test was performed to ensure that the participants&#x02019; levels of physical activity
corresponded to 30&#x02013;45% of VO<sub>2</sub>max uptake<xref rid="r32" ref-type="bibr">32</xref><sup>)</sup>.</p><p>Physical activity scores were estimated as previously reported using a pre-validated short
form of the International Physical Activity Questionnaire (IPAQ)<xref rid="r33" ref-type="bibr">33</xref>, <xref rid="r34" ref-type="bibr">34</xref><sup>)</sup>. The levels of
physical activity of all patients were estimated and calculated as metabolic equivalents
consumed during moderate, vigorous or normal daily physical exercise<xref rid="r35" ref-type="bibr">35</xref>, <xref rid="r36" ref-type="bibr">36</xref><sup>)</sup>. According to
physical activity (PA), the subjects were classified into three groups; low PA (600
MET&#x02013;min/week; n=25), moderate PA (&#x02265; 600 MET-&#x02005;min/week; n=15), and high PA (&#x02265; 3.000
MET-&#x02005;min/week; n=10).</p><p>All diabetes- related factors and cellular fibronectin were estimated from serum blood
samples collected from all participants before and after the training program.</p><p>Fasting blood glucose and glycosylated hemoglobin (HbA1c) were measured by routine
colorimetric techniques using commercial kits (for glucose, QuantiChrom Glucose Assay Kit,
DIGL-100, BioAssay Systems, Hayward, CA, USA; for HbA1c, Bio-Rad, Richmond, CA, USA). An
ELISA technique was used to estimate the level of insulin in serum of all subjects using an
ELISA kit (Insulin ELISA kit human, KAQ1251, Invitrogen Corporation, Camarillo, CA,
USA).</p><p>Homeostasis model assessment of insulin resistance (HOMA-IR) which has previously been
validated was used to measure insulin resistance in fasting state. The results IR were
significantly calculated in the fasting insulin (IF) and fasting glucose (GF) as follows:
HOMA-IRZ (IF!GF)/22.5<xref rid="r37" ref-type="bibr">37</xref>,<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r39" ref-type="bibr">39</xref><sup>)</sup>.</p><p>Circulating cFN was measured with an immune assay technique using an ELISA kit
(Sigma-Aldrich, St. Louis, MO, USA). The concentrations of cFN were measured
calorimetrically according to the manufacturer&#x02019;s instructions.</p><p>The obtained data were analyzed using the SPSS-16 software. In this study, quantitative
data are represented as the mean&#x000b1;SD. The paired sample t-test was used to compare changes
within groups, and the independent sample t-test was used to compare changes between groups.
p&#x0003c;0.05 was considered statistically significant.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>Fifty men who had a mean age of 48.8 &#x000b1; 14.6&#x02005;years and had been diagnosed with type 2
diabetes were participated in this study to evaluate the effect of supervised aerobic
training on the level of cFN. Clinical details of the subjects and the biochemical variables
under study are summarized in <xref rid="tbl_001" ref-type="table">Table 1</xref>. In the
exercise group, the patients with type 2 diabetes were characterized by a significantly
longer duration of diabetes and higher biochemical parameters compared with the control
subjects. The mean HbA1c and lipid profile concentrations were significantly higher in the
exercise group than in the control group (<xref rid="tbl_001" ref-type="table">Table
1</xref>).</p><p>There was a significant decrease (p=0.001) in fasting blood sugar, fasting insulin,
glycosylated hemoglobin (HbAc1), and insulin resistance following 12 weeks of moderate
aerobic training (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Mean &#x000b1; standard deviation (SD) and statistical comparison of the pre- and
post-training values of the studied variables in the aerobic exercise and control
groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="5" valign="middle" align="center" colspan="1">Variables</th><th colspan="6" valign="top" align="center" rowspan="1">Groups</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="3" valign="top" align="center" rowspan="1">Aerobic exercise (n=25)</th><th colspan="3" valign="top" align="center" rowspan="1">Control (n=25)</th></tr><tr><th colspan="3" rowspan="1"><hr/></th><th colspan="3" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Pretest</th><th valign="top" align="center" rowspan="1" colspan="1">Posttest</th><th valign="top" align="center" rowspan="1" colspan="1">Mean Diff.</th><th valign="top" align="center" rowspan="1" colspan="1">Pretest</th><th valign="top" align="center" rowspan="1" colspan="1">Posttest</th><th valign="top" align="center" rowspan="1" colspan="1">Mean Diff.</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">F.B. Sugar (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">197 &#x000b1; 92.8 </td><td align="center" valign="top" rowspan="1" colspan="1">146.3 &#x000b1; 21</td><td align="center" valign="top" rowspan="1" colspan="1">50.7 &#x000b1; 15***</td><td align="center" valign="top" rowspan="1" colspan="1">185 &#x000b1; 65.7</td><td align="center" valign="top" rowspan="1" colspan="1">184.3 &#x000b1; 58.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.7 &#x000b1; 0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbAc1 (%)</td><td align="center" valign="top" rowspan="1" colspan="1">8.7 &#x000b1; 1.2</td><td align="center" valign="top" rowspan="1" colspan="1">6.3 &#x000b1; 0.6 </td><td align="center" valign="top" rowspan="1" colspan="1">1.40 &#x000b1; 0.4** *</td><td align="center" valign="top" rowspan="1" colspan="1">9.1 &#x000b1; 0.9</td><td align="center" valign="top" rowspan="1" colspan="1">8.9 &#x000b1; 1.2</td><td align="center" valign="top" rowspan="1" colspan="1">0.2 &#x000b1; 0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F. insulin (&#x003bc;U/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">40.6 &#x000b1; 9.3</td><td align="center" valign="top" rowspan="1" colspan="1">25.7 &#x000b1; 6.8 </td><td align="center" valign="top" rowspan="1" colspan="1">14.9 &#x000b1; 3.5 ***</td><td align="center" valign="top" rowspan="1" colspan="1">41.5 &#x000b1; 3.7</td><td align="center" valign="top" rowspan="1" colspan="1">38.7 &#x000b1; 5.3 </td><td align="center" valign="top" rowspan="1" colspan="1">2.8 &#x000b1; 0.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IR (mU<sup>*</sup>mmol/L<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">5.9 &#x000b1; 1.4</td><td align="center" valign="top" rowspan="1" colspan="1">3.6 &#x000b1; 0.9 </td><td align="center" valign="top" rowspan="1" colspan="1">2.3 &#x000b1; 0.6*** </td><td align="center" valign="top" rowspan="1" colspan="1">4.3 &#x000b1;1.9</td><td align="center" valign="top" rowspan="1" colspan="1">4.19 &#x000b1; 1.5 </td><td align="center" valign="top" rowspan="1" colspan="1">0.11 &#x000b1; 0.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cellular fibronectin (cFN; &#x003bc;g/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">6.9 &#x000b1; 2.9</td><td align="center" valign="top" rowspan="1" colspan="1">3.2 &#x000b1; 1.2</td><td align="center" valign="top" rowspan="1" colspan="1">3.7 &#x000b1; 0.9***</td><td align="center" valign="top" rowspan="1" colspan="1">4.7 &#x000b1; 2.7</td><td align="center" valign="top" rowspan="1" colspan="1">4.6 &#x000b1; 1.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.1 &#x000b1; 0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg\m<sup>2</sup> )</td><td align="center" valign="top" rowspan="1" colspan="1">26.41 &#x000b1; 4.3</td><td align="center" valign="top" rowspan="1" colspan="1">23.5 &#x000b1; 2.7</td><td align="center" valign="top" rowspan="1" colspan="1">2.81 &#x000b1; 1.4*</td><td align="center" valign="top" rowspan="1" colspan="1">27.18 &#x000b1; 5.1</td><td align="center" valign="top" rowspan="1" colspan="1">26.9 &#x000b1; 6.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.28 &#x000b1; 0.7</td></tr></tbody></table><table-wrap-foot><p>F.B. sugar: fasting blood sugar; HbAc1: glycosylated hemoglobin, F.Insulin: fasting
insulin, IR: insulin resistance; BMI: body mass index. Data presented as the mean &#x000b1;SD.
The paired sample t-test revealed significant differences in within group comparisons
(*p&#x0003c;0.05, **p&#x0003c;0.01, ***p&#x0003c;0.001)</p></table-wrap-foot></table-wrap>). Also, there was a significant decrease in BMI and the cFN level (p=0.001) in
the patients following 12 weeks of moderate aerobic exercise. However, no significant
changes were observed in the control group after 12 weeks (p&#x0003e;0.05), and there were
significant correlation (p=0.01) between the decrease in cFN and the reductions in BMI,
fasting blood sugar, fasting insulin, glycosylated hemoglobin (HbAc1), and insulin
resistance, as shown in <xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Correlation between cellular fibronectin, BMI, and diabetic biomarkers in
patients with type 2 diabetes (n= 50)</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="5" valign="middle" align="center" colspan="1">Variables</th><th colspan="2" align="center" rowspan="1">Pre-training value</th><th colspan="2" align="center" rowspan="1">Post-training value</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">Cellular fibronectin (cFN)</th><th colspan="2" align="center" rowspan="1">Cellular fibronectin (cFN)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1">(95% CI)</th><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1">(95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">F.B. Sugar</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">75 (73&#x02013;98)</td><td align="center" rowspan="1" colspan="1">0.25<sup>**</sup></td><td align="center" rowspan="1" colspan="1">94 (87&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">HbAc1</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">80 (75&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.53<sup>**</sup></td><td align="center" rowspan="1" colspan="1">89 (77&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">F. insulin</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">68 (56&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.21<sup>**</sup></td><td align="center" rowspan="1" colspan="1">90 (86&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">IR</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">71 (65&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.41<sup>**</sup></td><td align="center" rowspan="1" colspan="1">94 (87&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg\m<sup>2</sup> )</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">78 (66&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.31<sup>**</sup></td><td align="center" rowspan="1" colspan="1">89 (75&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical activity</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Low</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">84 (65&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.18<sup>***</sup></td><td align="center" rowspan="1" colspan="1">78 (65&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">94 (85&#x02013;100)</td><td align="center" rowspan="1" colspan="1"> 0.12<sup>***</sup></td><td align="center" rowspan="1" colspan="1">92 (85&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">High</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">91 (75&#x02013;100)</td><td align="center" rowspan="1" colspan="1">0.14<sup>***</sup></td><td align="center" rowspan="1" colspan="1">93 (75&#x02013;100)</td></tr></tbody></table><table-wrap-foot><p>**p &#x0003c; 0.01; *** p &#x0003c; 0.001. 95% CI: 95% confidence interval</p></table-wrap-foot></table-wrap>.</p><p>In relation to the status of physical activity, there was positive significant correlation
(p=0.001) between the fibronectin level and the intensity of physical activity (low,
moderate, and high), as shown in <xref rid="tbl_003" ref-type="table">Table 3</xref>.
Furthermore, there was a significant decrease in the level of fibronectin in subjects with
moderate to high physical activity compared with those with low physical activity (sedentary
lifestyle).</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>The increasing prevalence of type 2 diabetes mellitus (T2DM) may relate to the increase in
overweight and obesity among adults. Population-based studies showed that T2DM is the
sixth-leading cause of death attributed to cardiovascular disease (CVD; nearly 70%)<xref rid="r40" ref-type="bibr">40</xref>, <xref rid="r41" ref-type="bibr">41</xref><sup>)</sup>.</p><p>Physical activity is one of the most pivotal targets for the prevention and management of
type 2 diabetes in both genders<xref rid="r42" ref-type="bibr">42</xref><sup>)</sup>. It was
reported that in patients with T2DM, physical activity can improve glycemic control, prevent
cardiovascular disease, and reduce the risk of cardiovascular and total mortality<xref rid="r43" ref-type="bibr">43</xref>, <xref rid="r44" ref-type="bibr">44</xref><sup>)</sup>.</p><p>Several studies reported that exercise training improved metabolic disorders, as measured
by HbA1c, blood glucose, or insulin sensitivity<xref rid="r45" ref-type="bibr">45</xref>,
<xref rid="r46" ref-type="bibr">46</xref><sup>)</sup>, but the effect of exercise training
on plasma cFN remains controversial. So, this present study aimed to investigate the effects
of moderate intensity of aerobic exercise training for 12 weeks on plasma cFN and its
relationship with reduction of body weight and improvements of insulin sensitivity among
type 2 diabetic subjects.</p><p>The results of this study showed a significant reduction of fasting blood sugar, fasting
insulin, glycosylated hemoglobin, and insulin resistance after 12 weeks of moderate aerobic
training combined with a significant reduction in BMI. However, there was no significant
change in control diabetic patients. The results of this study came are in agreement with
some previous studies that reported that cardiovascular-based moderate physical activity
along with modest weight loss of 5&#x02013;7% appeared to improve glycemic control and lowered the
risk of developing diabetes by 58% in overweight people with pre-diabetes<xref rid="r46" ref-type="bibr">46</xref>,<xref rid="r47" ref-type="bibr">47</xref>,<xref rid="r48" ref-type="bibr">48</xref><sup>)</sup>. Also, many studies have shown positive
health benefits with moderate-intensity exercise in patients with T2DM, whereas a
considerable improvement in HbA1c and cardiorespiratory fitness was reported in diabetic
subjects who performed cardio respiratory exercise with varying intensities<xref rid="r49" ref-type="bibr">49</xref>,<xref rid="r50" ref-type="bibr">50</xref>,<xref rid="r51" ref-type="bibr">51</xref><sup>)</sup>.</p><p>Hyperglycemia is the major causal factor in the development of endothelial dysfunction in
diabetes mellitus through changes in extracellular matrix proteins including cellular
fibronectin<xref rid="r52" ref-type="bibr">52</xref>, <xref rid="r53" ref-type="bibr">53</xref><sup>)</sup>, whereas elevated plasma levels of circulating cFN have been
described in diverse clinical syndromes with endothelial activation, including diabetes
mellitus, and cFN has been reported as a specific marker for endothelial cell injury<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>.</p><p>Cellular fibronectin is important as a marker of endothelial dysfunction in diabetes, and
the present study showed a significant increase in the level of cFN among patients with
T2DM. The data obtained matched with previous studies that reported the elevation of cFN
levels and suggested that circulating cellular fibronectin may be a marker protein for
endothelial cell activation, especially in diabetes<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>.</p><p>In the exercise group, a significant decrease in cFN concentration was reported in the
patients following 12 weeks of moderate aerobic training compared with the control diabetic
patients. The decrease in cFN levels showed significant positive correlations with the
reduction s in fasting blood sugar, fasting insulin, glycosylated hemoglobin, insulin
resistance, and body weight. The data are in line with previous studies that reported the
importance of regular exercise in evoking hemostatic changes against major thrombotic
events, especially improvement of the fibronectin level<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. Also, modulation of plasma fibronectin (PF) was reported in men
subjected to various intensities of physical exercise, whereas the PF level was suppressed
in men subjected to a long term exercise program for 8 weeks<xref rid="r54" ref-type="bibr">54</xref><sup>)</sup>. Expression of fibronectin, a glycoprotein that influences
stiffness by binding to extracellular matrix proteins including integrins, collagen, and
proteoglycans<xref rid="r55" ref-type="bibr">55</xref><sup>)</sup>, has been reported to
increase in the whole aorta with ageing in rats<xref rid="r56" ref-type="bibr">56</xref>,
<xref rid="r57" ref-type="bibr">57</xref><sup>)</sup>.</p><p>It was reported that individuals who perform regular aerobic exercise experienced less
age-associated stiffening of large elastic arteries compared with their sedentary peers<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>, as a result of the reduction in cFN protein level or modulation of
the mechanical function of fibronectin in muscle oxygenation during exercise, which dilates
the blood vessels and increases blood flow through the muscles<xref rid="r58" ref-type="bibr">58</xref><sup>)</sup>.</p><p>In this study, patients showed significant increase in insulin sensitivity following 12
weeks of moderate aerobic training. This improvement may related to an increase in signaling
process of post-receptor insulin<xref rid="r59" ref-type="bibr">59</xref><sup>)</sup> or by
an increase in the levels of glucose transporter protein and mRNA<xref rid="r60" ref-type="bibr">60</xref><sup>)</sup>, or activation of both glycogen syntheses and
hexokinase<xref rid="r61" ref-type="bibr">61</xref><sup>)</sup>, or by increasing
delivered glucose to muscles and finally by changes in muscle composition<xref rid="r62" ref-type="bibr">62</xref><sup>)</sup>.</p><p>The improvement of insulin resistance noted in this study could be also related to the
improvement of cFN ; fibronectin binds to insulin-like growth factor binding protein-5
(IGFBP-5), and this binding negatively regulates the ligand-dependent action of IGFBP-5 by
triggering its proteolysis<xref rid="r63" ref-type="bibr">63</xref>,<xref rid="r64" ref-type="bibr">64</xref>,<xref rid="r65" ref-type="bibr">65</xref>,<xref rid="r66" ref-type="bibr">66</xref><sup>)</sup>, On the other hand, the reduction in expression of insulin
receptor (InsR) was reported to be associated with enhanced activity of the insulin-like
growth factor-1 receptor (IGF-1R)/PI3&#x02005;K/Akt signaling pathway, which contributed in part to
the attenuation of cellular FN accumulation via an increasing in its degradation by the
action of matrix metalloproteinase enzymes (MMPs)<xref rid="r66" ref-type="bibr">66</xref>,
<xref rid="r67" ref-type="bibr">67</xref><sup>)</sup>.</p><p>In conclusion, the findings of this study showed that supervised aerobic exercise for 12
weeks may improve endothelial dysfunction by reducing plasma levels of cellular fibronectin
and improve of HbA1c, blood glucose, insulin sensitivity, and body weight in men with T2DM.
The data also suggested a significant correlation between cellular fibronectin level and
diabetic biomarkers along with body weight in men with T2DM.</p></sec></body><back><ack><p>The Project was full financially supported by King Saud University, through the Vice
Deanship of Research Chairs, Rehabilitation Research Chair.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Vassort</surname><given-names>G</given-names></name><name><surname>Turan</surname><given-names>B</given-names></name></person-group>: <article-title>Protective role of antioxidants in diabetes-induced
cardiac dysfunction</article-title>. <source>Cardiovasc Toxicol</source>,
<year>2010</year>, <volume>10</volume>: <fpage>73</fpage>&#x02013;<lpage>86</lpage>.
<pub-id pub-id-type="pmid">20458637</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Tan</surname><given-names>KC</given-names></name><name><surname>Chow</surname><given-names>WS</given-names></name><name><surname>Ai</surname><given-names>VH</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of angiotensin II receptor antagonist on
endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients
with microalbuminuria</article-title>. <source>Diabetes Metab Res Rev</source>,
<year>2002</year>, <volume>18</volume>: <fpage>71</fpage>&#x02013;<lpage>76</lpage>.
<pub-id pub-id-type="pmid">11921421</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Boden</surname><given-names>G</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name></person-group>: <article-title>Free fatty acids in obesity and type 2 diabetes: defining
their role in the development of insulin resistance and beta-cell
dysfunction</article-title>. <source>Eur J Clin Invest</source>, <year>2002</year>,
<volume>32</volume>: <fpage>14</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="pmid">12028371</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group>: <article-title>Fibronectins</article-title>. <source>Sci Am</source>,
<year>1986</year>, <volume>254</volume>: <fpage>42</fpage>&#x02013;<lpage>51</lpage>.
<pub-id pub-id-type="pmid">3010451</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Ruoslahti</surname><given-names>E</given-names></name></person-group>: <article-title>Fibronectin and its receptors</article-title>.
<source>Annu Rev Biochem</source>, <year>1988</year>, <volume>57</volume>:
<fpage>375</fpage>&#x02013;<lpage>413</lpage>. <pub-id pub-id-type="pmid">2972252</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Magnusson</surname><given-names>MK</given-names></name><name><surname>Mosher</surname><given-names>DF</given-names></name></person-group>: <article-title>Fibronectin: structure, assembly, and cardiovascular
implications</article-title>. <source>Arterioscler Thromb Vasc Biol</source>,
<year>1998</year>, <volume>18</volume>: <fpage>1363</fpage>&#x02013;<lpage>1370</lpage>.
<pub-id pub-id-type="pmid">9743223</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Peters</surname><given-names>JH</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name><name><surname>Bohl</surname><given-names>BP</given-names></name><etal>et al.</etal></person-group>: <article-title>Intravascular release of intact cellular fibronectin
during oxidant-induced injury of the in vitro perfused rabbit lung</article-title>.
<source>J Clin Invest</source>, <year>1986</year>, <volume>78</volume>:
<fpage>1596</fpage>&#x02013;<lpage>1603</lpage>. <pub-id pub-id-type="pmid">3023447</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Peters</surname><given-names>JH</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name><name><surname>Case</surname><given-names>CM</given-names></name><etal>et al.</etal></person-group>: <article-title>Release of soluble fibronectin containing an extra type
III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in
vivo</article-title>. <source>Am Rev Respir Dis</source>, <year>1988</year>,
<volume>138</volume>: <fpage>167</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="pmid">3202394</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Peters</surname><given-names>JH</given-names></name><name><surname>Maunder</surname><given-names>RJ</given-names></name><name><surname>Woolf</surname><given-names>AD</given-names></name><etal>et al.</etal></person-group>: <article-title>Elevated plasma levels of ED1+ (&#x0201c;cellular&#x0201d;) fibronectin in
patients with vascular injury</article-title>. <source>J Lab Clin Med</source>,
<year>1989</year>, <volume>113</volume>: <fpage>586</fpage>&#x02013;<lpage>597</lpage>.
<pub-id pub-id-type="pmid">2715681</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Lockwood</surname><given-names>CJ</given-names></name><name><surname>Peters</surname><given-names>JH</given-names></name></person-group>: <article-title>Increased plasma levels of ED1+ cellular fibronectin
precede the clinical signs of preeclampsia</article-title>. <source>Am J Obstet
Gynecol</source>, <year>1990</year>, <volume>162</volume>:
<fpage>358</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="pmid">2309814</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Kanters</surname><given-names>SD</given-names></name><name><surname>Banga</surname><given-names>JD</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Plasma levels of cellular fibronectin in
diabetes</article-title>. <source>Diabetes Care</source>, <year>2001</year>,
<volume>24</volume>: <fpage>323</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="pmid">11213886</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Boumaza</surname><given-names>S</given-names></name><name><surname>Arribas</surname><given-names>SM</given-names></name><name><surname>Osborne-Pellegrin</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Fenestrations of the carotid internal elastic lamina and
structural adaptation in stroke-prone spontaneously hypertensive rats</article-title>.
<source>Hypertension</source>, <year>2001</year>, <volume>37</volume>:
<fpage>1101</fpage>&#x02013;<lpage>1107</lpage>. <pub-id pub-id-type="pmid">11304510</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Atkinson</surname><given-names>J</given-names></name></person-group>: <article-title>Age-related medial elastocalcinosis in arteries:
mechanisms, animal models, and physiological consequences</article-title>. <source>J
Appl Physiol 1985</source>, <year>2008</year>, <volume>105</volume>:
<fpage>1643</fpage>&#x02013;<lpage>1651</lpage>. <pub-id pub-id-type="pmid">18772323</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Colwell</surname><given-names>JA</given-names></name></person-group>: <article-title>Effects of exercise on platelet function, coagulation, and
fibrinolysis</article-title>. <source>Diabetes Metab Rev</source>, <year>1986</year>,
<volume>1</volume>: <fpage>501</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="pmid">2941254</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Lucha-L&#x000f3;pez</surname><given-names>MO</given-names></name><name><surname>Lucha-L&#x000f3;pez</surname><given-names>AC</given-names></name><name><surname>Vidal-Peracho</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Impact of supervised physiotherapeutic exercises for obese
adults with diabetes mellitus type 2</article-title>. <source>J Phys Ther Sci</source>,
<year>2012</year>, <volume>24</volume>: <fpage>1299</fpage>&#x02013;<lpage>1305</lpage>.
</mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Karoline de Morais</surname><given-names>P</given-names></name><name><surname>Sales</surname><given-names>MM</given-names></name><name><surname>Alves de Almeida</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of aerobic exercise intensity on 24-h ambulatory
blood pressure in individuals with type 2 diabetes and prehypertension</article-title>.
<source>J Phys Ther Sci</source>, <year>2015</year>, <volume>27</volume>:
<fpage>51</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="pmid">25642036</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Eichner</surname><given-names>ER</given-names></name></person-group>: <article-title>Antithrombotic effects of exercise</article-title>.
<source>Am Fam Physician</source>, <year>1987</year>, <volume>36</volume>:
<fpage>207</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="pmid">3318359</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Alm&#x000e9;r</surname><given-names>LO</given-names></name><name><surname>Nilsson</surname><given-names>IM</given-names></name></person-group>: <article-title>On fibrinolysis in diabetes mellitus</article-title>.
<source>Acta Med Scand</source>, <year>1975</year>, <volume>198</volume>:
<fpage>101</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="pmid">52286</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>RS</given-names></name><name><surname>Logue</surname><given-names>EE</given-names></name><name><surname>Lewis</surname><given-names>JG</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical conditioning augments the fibrinolytic response
to venous occlusion in healthy adults</article-title>. <source>N Engl J Med</source>,
<year>1980</year>, <volume>302</volume>: <fpage>987</fpage>&#x02013;<lpage>991</lpage>.
<pub-id pub-id-type="pmid">7189244</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>ST</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of a 12-week healthy-life exercise program on
oxidized low-density lipoprotein cholesterol and carotid intima-media thickness in obese
elderly women</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>1435</fpage>&#x02013;<lpage>1439</lpage>. <pub-id pub-id-type="pmid">26157235</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>EG</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>KE</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of a walking program on self-management and risk
factors of metabolic syndrome in older korean adults</article-title>. <source>J Phys
Ther Sci</source>, <year>2014</year>, <volume>26</volume>:
<fpage>105</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="pmid">24567686</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Blair</surname><given-names>SN</given-names></name><name><surname>Kohl</surname><given-names>HW</given-names><suffix>3rd</suffix></name><name><surname>Paffenbarger</surname><given-names>RS</given-names><suffix>Jr</suffix></name><etal>et al.</etal></person-group>: <article-title>Physical fitness and all-cause mortality. A prospective
study of healthy men and women</article-title>. <source>JAMA</source>,
<year>1989</year>, <volume>262</volume>: <fpage>2395</fpage>&#x02013;<lpage>2401</lpage>.
<pub-id pub-id-type="pmid">2795824</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><etal>et al.</etal></person-group>: <article-title>Aging, habitual exercise, and dynamic arterial
compliance</article-title>. <source>Circulation</source>, <year>2000</year>,
<volume>102</volume>: <fpage>1270</fpage>&#x02013;<lpage>1275</lpage>. <pub-id pub-id-type="pmid">10982542</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Walker</surname><given-names>AE</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><etal>et al.</etal></person-group>: <article-title>Habitual exercise and vascular ageing</article-title>.
<source>J Physiol</source>, <year>2009</year>, <volume>587</volume>:
<fpage>5541</fpage>&#x02013;<lpage>5549</lpage>. <pub-id pub-id-type="pmid">19723776</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Lim</surname><given-names>ST</given-names></name><name><surname>Min</surname><given-names>SK</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of a healthy life exercise program on
arteriosclerosis adhesion molecules in elderly obese women</article-title>. <source>J
Phys Ther Sci</source>, <year>2015</year>, <volume>27</volume>:
<fpage>1529</fpage>&#x02013;<lpage>1532</lpage>. <pub-id pub-id-type="pmid">26157257</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>SX</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of combined aerobic and resistance training on the
glycolipid metabolism and inflammation levels in type 2 diabetes
mellitus</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>2365</fpage>&#x02013;<lpage>2371</lpage>. <pub-id pub-id-type="pmid">26311110</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Nosaka</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>I</given-names></name><etal>et al.</etal></person-group>: <article-title>Influence of regular exercise on age-related changes in
arterial elasticity: mechanistic insights from wall compositions in rat
aorta</article-title>. <source>Can J Appl Physiol</source>, <year>2003</year>,
<volume>28</volume>: <fpage>204</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="pmid">12825330</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal">American Diabetes
Association: <article-title>Standards of medical care in diabetes&#x02014;2009</article-title>.
<source>Diabetes Care</source>, <year>2009</year>, <volume>32</volume>:
<fpage>S13</fpage>&#x02013;<lpage>S61</lpage>. <pub-id pub-id-type="pmid">19118286</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Karvonen</surname><given-names>MJ</given-names></name><name><surname>Kentala</surname><given-names>E</given-names></name><name><surname>Mustala</surname><given-names>O</given-names></name></person-group>: <article-title>The effects of training on heart rate; a longitudinal
study</article-title>. <source>Ann Med Exp Biol Fenn</source>, <year>1957</year>,
<volume>35</volume>: <fpage>307</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="pmid">13470504</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Choi</surname><given-names>DH</given-names></name></person-group>: <article-title>Effects of walking and resistance training on the
bodycomposition, cardiorespiratory function, physical fitness and blood profiles of
middle-aged obese women</article-title>. <source>Exer Sci</source>, <year>2007</year>,
<volume>16</volume>: <fpage>85</fpage>&#x02013;<lpage>94</lpage>.</mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="book">ACSM: ACSMs Guidelines for
Exercise Testing and Prescription by American College of Sports Medicine, 8th ed.
Lippincott Williams &#x00026; Wilkins, <year>2009</year>.</mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Guezennec</surname><given-names>CY</given-names></name><name><surname>Satabin</surname><given-names>P</given-names></name><name><surname>Legrand</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical performance and metabolic changes induced by
combined prolonged exercise and different energy intakes in humans</article-title>.
<source>Eur J Appl Physiol Occup Physiol</source>, <year>1994</year>,
<volume>68</volume>: <fpage>525</fpage>&#x02013;<lpage>530</lpage>. <pub-id pub-id-type="pmid">7957146</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Booth</surname><given-names>M</given-names></name></person-group>: <article-title>Assessment of physical activity: an international
perspective</article-title>. <source>Res Q Exerc Sport</source>, <year>2000</year>,
<volume>71</volume>: <fpage>S114</fpage>&#x02013;<lpage>S120</lpage>. <pub-id pub-id-type="pmid">10925833</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>M&#x000e4;der</surname><given-names>U</given-names></name><name><surname>Martin</surname><given-names>BW</given-names></name><name><surname>Schutz</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group>: <article-title>Validity of four short physical activity questionnaires in
middle-aged persons</article-title>. <source>Med Sci Sports Exerc</source>,
<year>2006</year>, <volume>38</volume>: <fpage>1255</fpage>&#x02013;<lpage>1266</lpage>.
<pub-id pub-id-type="pmid">16826022</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Craig</surname><given-names>CL</given-names></name><name><surname>Marshall</surname><given-names>AL</given-names></name><name><surname>Sj&#x000f6;str&#x000f6;m</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>International physical activity questionnaire: 12-country
reliability and validity</article-title>. <source>Med Sci Sports Exerc</source>,
<year>2003</year>, <volume>35</volume>: <fpage>1381</fpage>&#x02013;<lpage>1395</lpage>.
<pub-id pub-id-type="pmid">12900694</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="eref">IPAQ website: <year>2008</year>
[<ext-link ext-link-type="uri" xlink:href="http://www.ipaq.ki.se/">http://www.ipaq.ki.se/</ext-link>].</mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><etal>et al.</etal></person-group>: <article-title>Homeostasis model assessment: insulin resistance and
beta-cell function from fasting plasma glucose and insulin concentrations in
man</article-title>. <source>Diabetologia</source>, <year>1985</year>,
<volume>28</volume>: <fpage>412</fpage>&#x02013;<lpage>419</lpage>. <pub-id pub-id-type="pmid">3899825</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Nishizawa</surname><given-names>Y</given-names></name><name><surname>Maekawa</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>Homeostasis model assessment as a clinical index of
insulin resistance in type 2 diabetic patients treated with
sulfonylureas</article-title>. <source>Diabetes Care</source>, <year>1999</year>,
<volume>22</volume>: <fpage>818</fpage>&#x02013;<lpage>822</lpage>. <pub-id pub-id-type="pmid">10332688</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Katsuki</surname><given-names>A</given-names></name><name><surname>Sumida</surname><given-names>Y</given-names></name><name><surname>Gabazza</surname><given-names>EC</given-names></name><etal>et al.</etal></person-group>: <article-title>Homeostasis model assessment is a reliable indicator of
insulin resistance during follow-up of patients with type 2 diabetes</article-title>.
<source>Diabetes Care</source>, <year>2001</year>, <volume>24</volume>:
<fpage>362</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="pmid">11213893</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Yoo</surname><given-names>JH</given-names></name><name><surname>So</surname><given-names>YS</given-names></name></person-group>: <article-title>Effect of the low- versus high-intensity exercise training
on endoplasmic reticulum stress and GLP-1 in adolescents with type 2 diabetes
mellitus</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>3063</fpage>&#x02013;<lpage>3068</lpage>. <pub-id pub-id-type="pmid">26644644</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="book">Centers for Disease Control and
Prevention: National Diabetes Fact Sheet: General Information and National Estimates of
Diabetes in the United States, 2007. Atlanta, Ga: US Department of Health and Human
Services, Centers for Disease Control and Prevention, <year>2008</year>.</mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Coady</surname><given-names>S</given-names></name><name><surname>Sorlie</surname><given-names>PD</given-names></name><etal>et al.</etal></person-group>: <article-title>Increasing cardiovascular disease burden due to diabetes
mellitus: the Framingham Heart Study</article-title>. <source>Circulation</source>,
<year>2007</year>, <volume>115</volume>: <fpage>1544</fpage>&#x02013;<lpage>1550</lpage>.
<pub-id pub-id-type="pmid">17353438</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Cadwell</surname><given-names>BL</given-names></name><etal>et al.</etal></person-group>: <article-title>Secular trends in cardiovascular disease risk factors
according to body mass index in US adults</article-title><comment>[published correction
appears in JAMA. 2005, 294:182]</comment>
<source>JAMA</source>, <year>2005</year>,
<volume>293</volume>: <fpage>1868</fpage>&#x02013;<lpage>1874</lpage>. <pub-id pub-id-type="pmid">15840861</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal">American Diabetes
Association: <article-title>Position statement. Diabetes mellitus and
exercise</article-title>. <source>Diabetes Care</source>, <year>2002</year>,
<volume>25</volume>: <fpage>S64</fpage>&#x02013;<lpage>S68</lpage>. </mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Barengo</surname><given-names>NC</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical activity, cardiovascular risk factors, and
mortality among Finnish adults with diabetes</article-title>. <source>Diabetes
Care</source>, <year>2005</year>, <volume>28</volume>:
<fpage>799</fpage>&#x02013;<lpage>805</lpage>. <pub-id pub-id-type="pmid">15793176</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="other"><person-group><name><surname>Dunstan</surname><given-names>DW</given-names></name><name><surname>Zimmt</surname><given-names>P</given-names></name><name><surname>Slade</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>: Diabetes and physical activity. Joint position statement of the
International Diabetes Institute and Diabetes Australia Victoria on the role of physical
activity in the risk reduction and management of diabetes. November
<year>2003</year>.</mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group><name><surname>Albright</surname><given-names>A</given-names></name><name><surname>Franz</surname><given-names>M</given-names></name><name><surname>Hornsby</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>: <article-title>American College of Sports Medicine position stand.
Exercise and type 2 diabetes</article-title>. <source>Med Sci Sports Exerc</source>,
<year>2000</year>, <volume>32</volume>: <fpage>1345</fpage>&#x02013;<lpage>1360</lpage>.
<pub-id pub-id-type="pmid">10912903</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group><name><surname>Goodyear</surname><given-names>LJ</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name></person-group>: <article-title>Exercise, glucose transport, and insulin
sensitivity</article-title>. <source>Annu Rev Med</source>, <year>1998</year>,
<volume>49</volume>: <fpage>235</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="pmid">9509261</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group><name><surname>Ahmadizad</surname><given-names>S</given-names></name><name><surname>Haghighi</surname><given-names>AH</given-names></name><name><surname>Hamedinia</surname><given-names>MR</given-names></name></person-group>: <article-title>Effects of resistance versus endurance training on serum
adiponectin and insulin resistance index</article-title>. <source>Eur J
Endocrinol</source>, <year>2007</year>, <volume>157</volume>:
<fpage>625</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="pmid">17984242</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wasserman</surname><given-names>DH</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical activity/exercise and type 2
diabetes</article-title>. <source>Diabetes Care</source>, <year>2004</year>,
<volume>27</volume>: <fpage>2518</fpage>&#x02013;<lpage>2539</lpage>. <pub-id pub-id-type="pmid">15451933</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><etal>et al.</etal></person-group>Finnish Diabetes Prevention Study Group: <article-title>Prevention of type
2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose
tolerance</article-title>. <source>N Engl J Med</source>, <year>2001</year>,
<volume>344</volume>: <fpage>1343</fpage>&#x02013;<lpage>1350</lpage>. <pub-id pub-id-type="pmid">11333990</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group><name><surname>Larsen</surname><given-names>JJ</given-names></name><name><surname>Dela</surname><given-names>F</given-names></name><name><surname>Madsbad</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>The effect of intense exercise on postprandial glucose
homeostasis in type II diabetic patients</article-title>. <source>Diabetologia</source>,
<year>1999</year>, <volume>42</volume>: <fpage>1282</fpage>&#x02013;<lpage>1292</lpage>.
<pub-id pub-id-type="pmid">10550411</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group><name><surname>Tessier</surname><given-names>D</given-names></name><name><surname>M&#x000e9;nard</surname><given-names>J</given-names></name><name><surname>F&#x000fc;l&#x000f6;p</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of aerobic physical exercise in the elderly with
type 2 diabetes mellitus</article-title>. <source>Arch Gerontol Geriatr</source>,
<year>2000</year>, <volume>31</volume>: <fpage>121</fpage>&#x02013;<lpage>132</lpage>.
<pub-id pub-id-type="pmid">11090907</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group><name><surname>Poirier</surname><given-names>P</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Broderick</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>: <article-title>Impact of moderate aerobic exercise training on insulin
sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin
sensitivity enhanced only in nonobese subjects?</article-title><source>Med Sci
Monit</source>, <year>2002</year>, <volume>8</volume>:
<fpage>CR59</fpage>&#x02013;<lpage>CR65</lpage>. <pub-id pub-id-type="pmid">11859274</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group><name><surname>Castaneda</surname><given-names>C</given-names></name><name><surname>Layne</surname><given-names>JE</given-names></name><name><surname>Munoz-Orians</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>: <article-title>A randomized controlled trial of resistance exercise
training to improve glycemic control in older adults with type 2
diabetes</article-title>. <source>Diabetes Care</source>, <year>2002</year>,
<volume>25</volume>: <fpage>2335</fpage>&#x02013;<lpage>2341</lpage>. <pub-id pub-id-type="pmid">12453982</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group><name><surname>Dastani</surname><given-names>M</given-names></name><name><surname>Rashidlamir</surname><given-names>A</given-names></name><name><surname>Alizadeh</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of 8 weeks of aerobic exercise on matrix
metalloproteinase-9 and tissue inhibitor levels in type II diabetic
women</article-title>. <source>Zahedan J Res Med Sci (ZJRMS)</source>,
<year>2013</year>, <fpage>29</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group><name><surname>DuBose</surname><given-names>DA</given-names></name><name><surname>Armstrong</surname><given-names>LE</given-names></name><name><surname>Kraemer</surname><given-names>WJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Modulation of human plasma fibronectin levels following
exercise</article-title>. <source>Aviat Space Environ Med</source>, <year>1989</year>,
<volume>60</volume>: <fpage>241</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="pmid">2712803</pub-id></mixed-citation></ref><ref id="r58"><label>58</label><mixed-citation publication-type="journal"><person-group><name><surname>Hynes</surname><given-names>RO</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name></person-group>: <article-title>Fibronectins: multifunctional modular
glycoproteins</article-title>. <source>J Cell Biol</source>, <year>1982</year>,
<volume>95</volume>: <fpage>369</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="pmid">6128348</pub-id></mixed-citation></ref><ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Froehlich</surname><given-names>J</given-names></name><name><surname>Galis</surname><given-names>ZS</given-names></name><etal>et al.</etal></person-group>: <article-title>Increased expression of matrix metalloproteinase-2 in the
thickened intima of aged rats</article-title>. <source>Hypertension</source>,
<year>1999</year>, <volume>33</volume>: <fpage>116</fpage>&#x02013;<lpage>123</lpage>.
<pub-id pub-id-type="pmid">9931091</pub-id></mixed-citation></ref><ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Spinetti</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>: <article-title>Matrix metalloproteinase 2 activation of transforming
growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged
arterial wall</article-title>. <source>Arterioscler Thromb Vasc Biol</source>,
<year>2006</year>, <volume>26</volume>: <fpage>1503</fpage>&#x02013;<lpage>1509</lpage>.
<pub-id pub-id-type="pmid">16690877</pub-id></mixed-citation></ref><ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group><name><surname>Hocking</surname><given-names>DC</given-names></name><name><surname>Titus</surname><given-names>PA</given-names></name><name><surname>Sumagin</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>: <article-title>Extracellular matrix fibronectin mechanically couples
skeletal muscle contraction with local vasodilation</article-title>. <source>Circ
Res</source>, <year>2008</year>, <volume>102</volume>:
<fpage>372</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="pmid">18032733</pub-id></mixed-citation></ref><ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group><name><surname>Dela</surname><given-names>F</given-names></name><name><surname>Handberg</surname><given-names>A</given-names></name><name><surname>Mikines</surname><given-names>KJ</given-names></name><etal>et al.</etal></person-group>: <article-title>GLUT 4 and insulin receptor binding and kinase activity in
trained human muscle</article-title>. <source>J Physiol</source>, <year>1993</year>,
<volume>469</volume>: <fpage>615</fpage>&#x02013;<lpage>624</lpage>. <pub-id pub-id-type="pmid">8271219</pub-id></mixed-citation></ref><ref id="r63"><label>63</label><mixed-citation publication-type="journal"><person-group><name><surname>Dela</surname><given-names>F</given-names></name><name><surname>Ploug</surname><given-names>T</given-names></name><name><surname>Handberg</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical training increases muscle GLUT4 protein and mRNA
in patients with NIDDM</article-title>. <source>Diabetes</source>, <year>1994</year>,
<volume>43</volume>: <fpage>862</fpage>&#x02013;<lpage>865</lpage>. <pub-id pub-id-type="pmid">8013748</pub-id></mixed-citation></ref><ref id="r64"><label>64</label><mixed-citation publication-type="journal"><person-group><name><surname>Oberbach</surname><given-names>A</given-names></name><name><surname>T&#x000f6;njes</surname><given-names>A</given-names></name><name><surname>Kl&#x000f6;ting</surname><given-names>N</given-names></name><etal>et al.</etal></person-group>: <article-title>Effect of a 4 week physical training program on plasma
concentrations of inflammatory markers in patients with abnormal glucose
tolerance</article-title>. <source>Eur J Endocrinol</source>, <year>2006</year>,
<volume>154</volume>: <fpage>577</fpage>&#x02013;<lpage>585</lpage>. <pub-id pub-id-type="pmid">16556721</pub-id></mixed-citation></ref><ref id="r65"><label>65</label><mixed-citation publication-type="journal"><person-group><name><surname>Klimcakova</surname><given-names>E</given-names></name><name><surname>Polak</surname><given-names>J</given-names></name><name><surname>Moro</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Dynamic strength training improves insulin sensitivity
without altering plasma levels and gene expression of adipokines in subcutaneous adipose
tissue in obese men</article-title>. <source>J Clin Endocrinol Metab</source>,
<year>2006</year>, <volume>91</volume>: <fpage>5107</fpage>&#x02013;<lpage>5112</lpage>.
<pub-id pub-id-type="pmid">16968804</pub-id></mixed-citation></ref><ref id="r66"><label>66</label><mixed-citation publication-type="journal"><person-group><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Fibronectin binds insulin-like growth factor-binding
protein 5 and abolishes Its ligand-dependent action on cell migration</article-title>.
<source>J Biol Chem</source>, <year>2004</year>, <volume>279</volume>:
<fpage>4269</fpage>&#x02013;<lpage>4277</lpage>. <pub-id pub-id-type="pmid">14645245</pub-id></mixed-citation></ref><ref id="r67"><label>67</label><mixed-citation publication-type="journal"><person-group><name><surname>Yano</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>D</given-names></name><name><surname>Endoh</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>In vitro silencing of the insulin receptor attenuates
cellular accumulation of fibronectin in renal mesangial cells</article-title>.
<source>Cell Commun Signal</source>, <year>2012</year>, <volume>10</volume>:
<fpage>29</fpage>. <pub-id pub-id-type="pmid">23061721</pub-id></mixed-citation></ref></ref-list></back></article>